Paroxetine System Suitability Mixture A

NA

(piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-) and (piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)-, hydrochloride (3S-trans)-) and (piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-phenyl-, hydrochloride (3S-trans)-); Mixture of paroxetine hydrochloride, paroxetine related compound A and paroxetine related compound B; Mixture of approximately 1% paroxetine related compound A [piperidine, 3-{(1,3-benzodioxol-5-yloxy)methyl}-4-(4-methoxyphenyl)-,hydrochloride (3S -trans)]; and 1% of paroxetine related compound B [(3S ,4R )-3-[(benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride]; Paroxetine System Suitability Mixture A (USP);